Reply
- PMID: 30803529
- DOI: 10.1016/j.ophtha.2018.12.005
Reply
Comment on
-
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis.Ophthalmology. 2019 Mar;126(3):415-424. doi: 10.1016/j.ophtha.2018.09.043. Epub 2018 Oct 16. Ophthalmology. 2019. PMID: 30336181 Clinical Trial.
-
Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).Ophthalmology. 2019 Mar;126(3):e22-e24. doi: 10.1016/j.ophtha.2018.12.004. Ophthalmology. 2019. PMID: 30803528 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
